Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
GEMCITABINE HCL 200MG RECON SOLN 200 (CDM 17121) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 28, 2026 , from http://ppman.hank.ai/transparency/procedure/17121/by-state?code_type=CDM
“GEMCITABINE HCL 200MG RECON SOLN 200 (CDM 17121) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/17121/by-state?code_type=CDM. Accessed
June 28, 2026 .
“GEMCITABINE HCL 200MG RECON SOLN 200 (CDM 17121) by State,” HANK Price Transparency ,
accessed June 28, 2026 ,
http://ppman.hank.ai/transparency/procedure/17121/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
17121 — Gemcitabine Hcl 200mg Recon Soln 200
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$37
National median
$31 – $430
IQR (p25 – p75)
5
hospitals filing
3
states
Walking in without insurance?
Cash / self-pay price
Cash median
$23
vs. negotiated
-37.7%
Hospitals reporting
23
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 17121 (CDM), with interquartile range
State Median p25 p75
ME $29,997 $16,623 $32,491
MA $817 $817 $817
WI $35 $29 $43